259 related articles for article (PubMed ID: 9917431)
21. Hyperbilirubinemia in the term newborn.
Porter ML; Dennis BL
Am Fam Physician; 2002 Feb; 65(4):599-606. PubMed ID: 11871676
[TBL] [Abstract][Full Text] [Related]
22. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns.
Alpay F; Sarici SU; Tosuncuk HD; Serdar MA; Inanç N; Gökçay E
Pediatrics; 2000 Aug; 106(2):E16. PubMed ID: 10920172
[TBL] [Abstract][Full Text] [Related]
23. Treatment of hyperbilirubinemia pharmacologic approach SnMP(tin-mesoporphyrin).
Martínez JC; García HO; Otheguy LE; Drummond GS; Kappas A
J Perinatol; 2001 Dec; 21 Suppl 1():S101-3; discussion S104-7. PubMed ID: 11803428
[No Abstract] [Full Text] [Related]
24. The effectiveness of oral tin mesoporphyrin prophylaxis in reducing bilirubin production after an oral heme load in a transgenic mouse model.
DeSandre GH; Wong RJ; Morioka I; Contag CH; Stevenson DK
Biol Neonate; 2006; 89(3):139-46. PubMed ID: 16205054
[TBL] [Abstract][Full Text] [Related]
25. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia. Inhibition of heme oxidation and bilirubin production.
Simionatto CS; Anderson KE; Drummond GS; Kappas A
J Clin Invest; 1985 Feb; 75(2):513-21. PubMed ID: 3838318
[TBL] [Abstract][Full Text] [Related]
27. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia.
Harris MC; Bernbaum JC; Polin JR; Zimmerman R; Polin RA
Pediatrics; 2001 May; 107(5):1075-80. PubMed ID: 11331689
[TBL] [Abstract][Full Text] [Related]
28. Metalloporphyrins in the management of neonatal hyperbilirubinemia.
Stevenson DK; Wong RJ
Semin Fetal Neonatal Med; 2010 Jun; 15(3):164-8. PubMed ID: 20006567
[TBL] [Abstract][Full Text] [Related]
29. Targeted delivery of a heme oxygenase inhibitor with a lyophilized liposomal tin mesoporphyrin formulation.
Cannon JB; Martin C; Drummond GS; Kappas A
Pharm Res; 1993 May; 10(5):715-21. PubMed ID: 8321837
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of severe neonatal hyperbilirubinemia.
Drummond GS; Kappas A
Semin Perinatol; 2004 Oct; 28(5):365-8. PubMed ID: 15686268
[TBL] [Abstract][Full Text] [Related]
31. Suppression of bilirubin production in the Crigler-Najjar type I syndrome: studies with the heme oxygenase inhibitor tin-mesoporphyrin.
Galbraith RA; Drummond GS; Kappas A
Pediatrics; 1992 Feb; 89(2):175-82. PubMed ID: 1734381
[TBL] [Abstract][Full Text] [Related]
32. Rebound in serum bilirubin level following intensive phototherapy.
Maisels MJ; Kring E
Arch Pediatr Adolesc Med; 2002 Jul; 156(7):669-72. PubMed ID: 12090833
[TBL] [Abstract][Full Text] [Related]
33. Transcutaneous bilirubin in exclusively breastfed healthy term newborns up to 12 days of life.
Draque CM; Sañudo A; de Araujo Peres C; de Almeida MF
Pediatrics; 2011 Sep; 128(3):e565-71. PubMed ID: 21873703
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemia.
Knüpfer M; Pulzer F; Gebauer C; Robel-Tillig E; Vogtmann C
Acta Paediatr; 2005 May; 94(5):581-7. PubMed ID: 16188747
[TBL] [Abstract][Full Text] [Related]
35. Weight loss and jaundice in healthy term newborns in partial and full rooming-in.
Zuppa AA; Sindico P; Antichi E; Carducci C; Alighieri G; Cardiello V; Cota F; Romagnoli C
J Matern Fetal Neonatal Med; 2009 Sep; 22(9):801-5. PubMed ID: 19526430
[TBL] [Abstract][Full Text] [Related]
36. Extreme hyperbilirubinemia in newborn infants.
Tiker F; Gulcan H; Kilicdag H; Tarcan A; Gurakan B
Clin Pediatr (Phila); 2006 Apr; 45(3):257-61. PubMed ID: 16708139
[TBL] [Abstract][Full Text] [Related]
37. Bilirubin conjugation, reflected by conjugated bilirubin fractions, in glucose-6-phosphate dehydrogenase-deficient neonates: a determining factor in the pathogenesis of hyperbilirubinemia.
Kaplan M; Muraca M; Hammerman C; Vilei MT; Leiter C; Rudensky B; Rubaltelli FF
Pediatrics; 1998 Sep; 102(3):E37. PubMed ID: 9724685
[TBL] [Abstract][Full Text] [Related]
38. Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coombs-positive ABO incompatibility.
Kappas A; Drummond GS; Manola T; Petmezaki S; Valaes T
Pediatrics; 1988 Apr; 81(4):485-97. PubMed ID: 3281127
[TBL] [Abstract][Full Text] [Related]
39. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.
Bhutani VK; Johnson L; Sivieri EM
Pediatrics; 1999 Jan; 103(1):6-14. PubMed ID: 9917432
[TBL] [Abstract][Full Text] [Related]
40. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions.
Martinez JC; Maisels MJ; Otheguy L; Garcia H; Savorani M; Mogni B; Martinez JC
Pediatrics; 1993 Feb; 91(2):470-3. PubMed ID: 8424029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
